591 related articles for article (PubMed ID: 33252199)
1. Head-to-head comparison of clinical performance of CSF phospho-tau T181 and T217 biomarkers for Alzheimer's disease diagnosis.
Karikari TK; Emeršič A; Vrillon A; Lantero-Rodriguez J; Ashton NJ; Kramberger MG; Dumurgier J; Hourregue C; Čučnik S; Brinkmalm G; Rot U; Zetterberg H; Paquet C; Blennow K
Alzheimers Dement; 2021 May; 17(5):755-767. PubMed ID: 33252199
[TBL] [Abstract][Full Text] [Related]
2. Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study.
Thijssen EH; La Joie R; Strom A; Fonseca C; Iaccarino L; Wolf A; Spina S; Allen IE; Cobigo Y; Heuer H; VandeVrede L; Proctor NK; Lago AL; Baker S; Sivasankaran R; Kieloch A; Kinhikar A; Yu L; Valentin MA; Jeromin A; Zetterberg H; Hansson O; Mattsson-Carlgren N; Graham D; Blennow K; Kramer JH; Grinberg LT; Seeley WW; Rosen H; Boeve BF; Miller BL; Teunissen CE; Rabinovici GD; Rojas JC; Dage JL; Boxer AL;
Lancet Neurol; 2021 Sep; 20(9):739-752. PubMed ID: 34418401
[TBL] [Abstract][Full Text] [Related]
3. Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort.
Mendes AJ; Ribaldi F; Lathuiliere A; Ashton NJ; Janelidze S; Zetterberg H; Scheffler M; Assal F; Garibotto V; Blennow K; Hansson O; Frisoni GB
J Neurol; 2024 Apr; 271(4):2053-2066. PubMed ID: 38195896
[TBL] [Abstract][Full Text] [Related]
4. Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays.
Leuzy A; Janelidze S; Mattsson-Carlgren N; Palmqvist S; Jacobs D; Cicognola C; Stomrud E; Vanmechelen E; Dage JL; Hansson O
Neurology; 2021 Oct; 97(17):e1681-e1694. PubMed ID: 34493616
[TBL] [Abstract][Full Text] [Related]
5. Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease.
Janelidze S; Bali D; Ashton NJ; Barthélemy NR; Vanbrabant J; Stoops E; Vanmechelen E; He Y; Dolado AO; Triana-Baltzer G; Pontecorvo MJ; Zetterberg H; Kolb H; Vandijck M; Blennow K; Bateman RJ; Hansson O
Brain; 2023 Apr; 146(4):1592-1601. PubMed ID: 36087307
[TBL] [Abstract][Full Text] [Related]
6. Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts.
Lantero-Rodriguez J; Vrillon A; Fernández-Lebrero A; Ortiz-Romero P; Snellman A; Montoliu-Gaya L; Brum WS; Cognat E; Dumurgier J; Puig-Pijoan A; Navalpotro-Gómez I; García-Escobar G; Karikari TK; Vanmechelen E; Ashton NJ; Zetterberg H; Suárez-Calvet M; Paquet C; Blennow K
Alzheimers Res Ther; 2023 Mar; 15(1):48. PubMed ID: 36899441
[TBL] [Abstract][Full Text] [Related]
7. Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays.
Ashton NJ; Puig-Pijoan A; Milà-Alomà M; Fernández-Lebrero A; García-Escobar G; González-Ortiz F; Kac PR; Brum WS; Benedet AL; Lantero-Rodriguez J; Day TA; Vanbrabant J; Stoops E; Vanmechelen E; Triana-Baltzer G; Moughadam S; Kolb H; Ortiz-Romero P; Karikari TK; Minguillon C; Hernández Sánchez JJ; Navalpotro-Gómez I; Grau-Rivera O; María Manero R; Puente-Periz V; de la Torre R; Roquer J; Dage JL; Zetterberg H; Blennow K; Suárez-Calvet M
Alzheimers Dement; 2023 May; 19(5):1913-1924. PubMed ID: 36370462
[TBL] [Abstract][Full Text] [Related]
8. Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.
Palmqvist S; Janelidze S; Quiroz YT; Zetterberg H; Lopera F; Stomrud E; Su Y; Chen Y; Serrano GE; Leuzy A; Mattsson-Carlgren N; Strandberg O; Smith R; Villegas A; Sepulveda-Falla D; Chai X; Proctor NK; Beach TG; Blennow K; Dage JL; Reiman EM; Hansson O
JAMA; 2020 Aug; 324(8):772-781. PubMed ID: 32722745
[TBL] [Abstract][Full Text] [Related]
9. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
[TBL] [Abstract][Full Text] [Related]
10. Comparison of CSF phosphorylated tau 181 and 217 for cognitive decline.
Mielke MM; Aakre JA; Algeciras-Schimnich A; Proctor NK; Machulda MM; Eichenlaub U; Knopman DS; Vemuri P; Graff-Radford J; Jack CR; Petersen RC; Dage JL
Alzheimers Dement; 2022 Apr; 18(4):602-611. PubMed ID: 34310832
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease.
Janelidze S; Stomrud E; Smith R; Palmqvist S; Mattsson N; Airey DC; Proctor NK; Chai X; Shcherbinin S; Sims JR; Triana-Baltzer G; Theunis C; Slemmon R; Mercken M; Kolb H; Dage JL; Hansson O
Nat Commun; 2020 Apr; 11(1):1683. PubMed ID: 32246036
[TBL] [Abstract][Full Text] [Related]
12. Plasma P-tau181 and P-tau217 in Patients With Traumatic Encephalopathy Syndrome With and Without Evidence of Alzheimer Disease Pathology.
Asken BM; Tanner JA; VandeVrede L; Mantyh WG; Casaletto KB; Staffaroni AM; La Joie R; Iaccarino L; Soleimani-Meigooni D; Rojas JC; Gardner RC; Miller BL; Grinberg LT; Boxer AL; Kramer JH; Rabinovici GD
Neurology; 2022 Aug; 99(6):e594-e604. PubMed ID: 35577574
[TBL] [Abstract][Full Text] [Related]
13. Plasma p-tau231: a new biomarker for incipient Alzheimer's disease pathology.
Ashton NJ; Pascoal TA; Karikari TK; Benedet AL; Lantero-Rodriguez J; Brinkmalm G; Snellman A; Schöll M; Troakes C; Hye A; Gauthier S; Vanmechelen E; Zetterberg H; Rosa-Neto P; Blennow K
Acta Neuropathol; 2021 May; 141(5):709-724. PubMed ID: 33585983
[TBL] [Abstract][Full Text] [Related]
14. Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease.
Therriault J; Servaes S; Tissot C; Rahmouni N; Ashton NJ; Benedet AL; Karikari TK; Macedo AC; Lussier FZ; Stevenson J; Wang YT; Fernandez-Arias J; Stevenson A; Socualaya KQ; Haeger A; Nazneen T; Aumont É; Hosseini A; Rej S; Vitali P; Triana-Baltzer G; Kolb HC; Soucy JP; Pascoal TA; Gauthier S; Zetterberg H; Blennow K; Rosa-Neto P
Alzheimers Dement; 2023 Nov; 19(11):4967-4977. PubMed ID: 37078495
[TBL] [Abstract][Full Text] [Related]
15. CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals.
Simrén J; Brum WS; Ashton NJ; Benedet AL; Karikari TK; Kvartsberg H; Sjons E; Lussier FZ; Chamoun M; Stevenson J; Hopewell R; Pallen V; Ye K; Pascoal TA; Zetterberg H; Rosa-Neto P; Blennow K
Alzheimers Res Ther; 2022 Dec; 14(1):192. PubMed ID: 36544221
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology.
Ashton NJ; Brum WS; Di Molfetta G; Benedet AL; Arslan B; Jonaitis E; Langhough RE; Cody K; Wilson R; Carlsson CM; Vanmechelen E; Montoliu-Gaya L; Lantero-Rodriguez J; Rahmouni N; Tissot C; Stevenson J; Servaes S; Therriault J; Pascoal T; Lleó A; Alcolea D; Fortea J; Rosa-Neto P; Johnson S; Jeromin A; Blennow K; Zetterberg H
JAMA Neurol; 2024 Mar; 81(3):255-263. PubMed ID: 38252443
[TBL] [Abstract][Full Text] [Related]
17. Mitigating the Associations of Kidney Dysfunction With Blood Biomarkers of Alzheimer Disease by Using Phosphorylated Tau to Total Tau Ratios.
Janelidze S; Barthélemy NR; He Y; Bateman RJ; Hansson O
JAMA Neurol; 2023 May; 80(5):516-522. PubMed ID: 36987840
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated tau in Alzheimer's disease.
Telser J; Grossmann K; Wohlwend N; Risch L; Saely CH; Werner P
Adv Clin Chem; 2023; 116():31-111. PubMed ID: 37852722
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid p-tau181, 217, and 231 in definite Creutzfeldt-Jakob disease with and without concomitant pathologies.
Emeršič A; Ashton NJ; Vrillon A; Lantero-Rodriguez J; Mlakar J; Gregorič Kramberger M; Gonzalez-Ortiz F; Kac PR; Dulewicz M; Hanrieder J; Vanmechelen E; Rot U; Zetterberg H; Karikari TK; Čučnik S; Blennow K
Alzheimers Dement; 2024 Jun; ():. PubMed ID: 38924651
[TBL] [Abstract][Full Text] [Related]
20. The Bio-Hermes Study: Biomarker database developed to investigate blood-based and digital biomarkers in community-based, diverse populations clinically screened for Alzheimer's disease.
Mohs RC; Beauregard D; Dwyer J; Gaudioso J; Bork J; MaGee-Rodgers T; Key MN; Kerwin DR; Hughes L; Cordell CB;
Alzheimers Dement; 2024 Apr; 20(4):2752-2765. PubMed ID: 38415908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
